These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 8117626

  • 1. Wild-type p53 tumor suppressor gene restores differentiation of human squamous carcinoma cells but not the response to transforming growth factor beta.
    Brenner L, Muñoz-Antonia T, Vellucci VF, Zhou ZL, Reiss M.
    Cell Growth Differ; 1993 Dec; 4(12):993-1004. PubMed ID: 8117626
    [Abstract] [Full Text] [Related]

  • 2. Implication of retinoic acid receptor gamma in squamous differentiation and response to retinoic acid in head and neck SqCC/Y1 squamous carcinoma cells.
    Oridate N, Esumi N, Lotan D, Hing WK, Rochette-Egly C, Chambon P, Lotan R.
    Oncogene; 1996 May 02; 12(9):2019-28. PubMed ID: 8649863
    [Abstract] [Full Text] [Related]

  • 3. Status of the p53 tumor suppressor gene in human squamous carcinoma cell lines.
    Reiss M, Brash DE, Muñoz-Antonia T, Simon JA, Ziegler A, Vellucci VF, Zhou ZL.
    Oncol Res; 1992 May 02; 4(8-9):349-57. PubMed ID: 1486218
    [Abstract] [Full Text] [Related]

  • 4. Combination E2F-1 and p53 gene transfer does not enhance growth inhibition in human squamous cell carcinoma of the head and neck.
    Frank DK, Liu TJ, Frederick MJ, Clayman GL.
    Clin Cancer Res; 1998 Sep 02; 4(9):2265-72. PubMed ID: 9748148
    [Abstract] [Full Text] [Related]

  • 5. Overexpression of wild-type p53 alters growth and differentiation of normal human keratinocytes but not human papillomavirus-expressing cell lines.
    Woodworth CD, Wang H, Simpson S, Alvarez-Salas LM, Notario V.
    Cell Growth Differ; 1993 May 02; 4(5):367-76. PubMed ID: 7686043
    [Abstract] [Full Text] [Related]

  • 6. Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis.
    Andrews GA, Xi S, Pomerantz RG, Lin CJ, Gooding WE, Wentzel AL, Wu L, Sidransky D, Grandis JR.
    Head Neck; 2004 Oct 02; 26(10):870-7. PubMed ID: 15390206
    [Abstract] [Full Text] [Related]

  • 7. The tumor suppressor gene p53 can mediate transforming growth [corrected] factor beta1-induced differentiation of leukemic cells independently of activation of the retinoblastoma protein.
    Ehinger M, Bergh G, Johnsson E, Gullberg U, Olsson I.
    Cell Growth Differ; 1997 Oct 02; 8(10):1127-37. PubMed ID: 9342191
    [Abstract] [Full Text] [Related]

  • 8. Involvement of the tumor suppressor gene p53 in tumor necrosis factor-induced differentiation of the leukemic cell line K562.
    Ehinger M, Nilsson E, Persson AM, Olsson I, Gullberg U.
    Cell Growth Differ; 1995 Jan 02; 6(1):9-17. PubMed ID: 7718488
    [Abstract] [Full Text] [Related]

  • 9. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines.
    Crowe DL, Sinha UK.
    Head Neck; 2006 Jan 02; 28(1):15-23. PubMed ID: 16302195
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of human papillomavirus-16 infection on CD8+ T-cell recognition of a wild-type sequence p53264-272 peptide in patients with squamous cell carcinoma of the head and neck.
    Sirianni N, Ha PK, Oelke M, Califano J, Gooding W, Westra W, Whiteside TL, Koch WM, Schneck JP, DeLeo A, Ferris RL.
    Clin Cancer Res; 2004 Oct 15; 10(20):6929-37. PubMed ID: 15501971
    [Abstract] [Full Text] [Related]

  • 13. Head and neck squamous cell growth suppression using adenovirus-p53-FLAG: a potential marker for gene therapy trials.
    Overholt SM, Liu TJ, Taylor DL, Wang M, El-Naggar AK, Shillitoe E, Adler-Storthz K, John LS, Zhang WW, Roth JA, Clayman GL.
    Clin Cancer Res; 1997 Feb 15; 3(2):185-91. PubMed ID: 9815671
    [Abstract] [Full Text] [Related]

  • 14. P53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines.
    Bradford CR, Zhu S, Ogawa H, Ogawa T, Ubell M, Narayan A, Johnson G, Wolf GT, Fisher SG, Carey TE.
    Head Neck; 2003 Aug 15; 25(8):654-61. PubMed ID: 12884349
    [Abstract] [Full Text] [Related]

  • 15. Mutant p53 tumor suppressor gene causes resistance to transforming growth factor beta 1 in murine keratinocytes.
    Reiss M, Vellucci VF, Zhou ZL.
    Cancer Res; 1993 Feb 15; 53(4):899-904. PubMed ID: 8094035
    [Abstract] [Full Text] [Related]

  • 16. Early ultraviolet B-induced G1 arrest and suppression of the malignant phenotype by wild-type p53 in human squamous cell carcinoma cells.
    Courtois SJ, Woodworth CD, Degreef H, Garmyn M.
    Exp Cell Res; 1997 May 25; 233(1):135-44. PubMed ID: 9184083
    [Abstract] [Full Text] [Related]

  • 17. Functional characterization of transforming growth factor beta type II receptor mutants in human cancer.
    De M, Yan W, de Jonge RR, Garrigue-Antar L, Vellucci VF, Reiss M.
    Cancer Res; 1998 May 01; 58(9):1986-92. PubMed ID: 9581843
    [Abstract] [Full Text] [Related]

  • 18. Tumor suppressor proteins as regulators of cell differentiation.
    Li ZR, Hromchak R, Mudipalli A, Bloch A.
    Cancer Res; 1998 Oct 01; 58(19):4282-7. PubMed ID: 9766653
    [Abstract] [Full Text] [Related]

  • 19. Overexpression of p53-related proteins predicts rapid growth rate of head and neck cancer.
    Edström S, Cvetkovska E, Westin T, Young C.
    Laryngoscope; 2001 Jan 01; 111(1):124-30. PubMed ID: 11192880
    [Abstract] [Full Text] [Related]

  • 20. TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrest.
    Paterson IC, Davies M, Stone A, Huntley S, Smith E, Pring M, Eveson JW, Robinson CM, Parkinson EK, Prime SS.
    Oncogene; 2002 Feb 28; 21(10):1616-24. PubMed ID: 11896591
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.